 evalu antibodi viru studi transfusion-associ hepat background hepat viru hcv chief caus transfusion-associ non-a non-b hepat preval hcv blood donor frequenc transmiss blood transfus unknown method sensit specif test antibodi hcv serum sampl particip larg studi transfusion-associ hepat sampl consecut adult open-heart surgeri spain antibodi anti-hcv avail result transfus recipi total unit blood percent transfusion-associ non-a non-b hepat mean follow-up week anti-hcv-posit percent transfus recipi donor avail percent anti-hcv antibodi addit seroposit donor implic donor seroneg month recipi anti-hcv-posit blood percent hepat anti-hcv-posit recipi hepat anti-hcv antibodi patient non-a non-b hepat blood posit anti-hcv conclus percent blood donor antibodi hcv infecti viru blood screen blood donor anti-hcv antibodi case transfusion-associ hepat donor infecti viru anti-hcv-neg seroneg prolong period